436 related articles for article (PubMed ID: 31109961)
1. Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry.
Popova D; Desai N; Blendy JA; Pang ZP
J Neurosci; 2019 Jul; 39(29):5685-5696. PubMed ID: 31109961
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol.
Scarnati MS; Boreland AJ; Joel M; Hart RP; Pang ZP
Alcohol; 2020 Sep; 87():97-109. PubMed ID: 32561311
[TBL] [Abstract][Full Text] [Related]
4. Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons.
Halikere A; Popova D; Scarnati MS; Hamod A; Swerdel MR; Moore JC; Tischfield JA; Hart RP; Pang ZP
Mol Psychiatry; 2020 Jul; 25(7):1406-1419. PubMed ID: 31481756
[TBL] [Abstract][Full Text] [Related]
5. Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function.
Mague SD; Port RG; McMullen ME; Carlson GC; Turner JR
Neuropharmacology; 2015 Oct; 97():426-35. PubMed ID: 25986698
[TBL] [Abstract][Full Text] [Related]
6. Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G.
Wang YJ; Huang P; Blendy JA; Liu-Chen LY
Addict Biol; 2014 May; 19(3):354-61. PubMed ID: 22862850
[TBL] [Abstract][Full Text] [Related]
7. Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism.
Robinson JE; Vardy E; DiBerto JF; Chefer VI; White KL; Fish EW; Chen M; Gigante E; Krouse MC; Sun H; Thorsell A; Roth BL; Heilig M; Malanga CJ
Neuropsychopharmacology; 2015 Oct; 40(11):2614-22. PubMed ID: 25881115
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of the μ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G.
Wang YJ; Huang P; Ung A; Blendy JA; Liu-Chen LY
Neuroscience; 2012 Mar; 205():178-84. PubMed ID: 22240251
[TBL] [Abstract][Full Text] [Related]
9. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior.
Mague SD; Isiegas C; Huang P; Liu-Chen LY; Lerman C; Blendy JA
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10847-52. PubMed ID: 19528658
[TBL] [Abstract][Full Text] [Related]
10. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
11. Mice Expressing Regulators of G protein Signaling-insensitive Gαo Define Roles of
Bouchet CA; McPherson KB; Li MH; Traynor JR; Ingram SL
Mol Pharmacol; 2021 Sep; 100(3):217-223. PubMed ID: 34135098
[TBL] [Abstract][Full Text] [Related]
12. Effects of mu-opioid receptor modulation on GABAB receptor synaptic function in hippocampal CA1.
McQuiston AR
J Neurophysiol; 2007 Mar; 97(3):2301-11. PubMed ID: 17215502
[TBL] [Abstract][Full Text] [Related]
13. Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat.
Briand LA; Hilario M; Dow HC; Brodkin ES; Blendy JA; Berton O
J Neurosci; 2015 Feb; 35(8):3582-90. PubMed ID: 25716856
[TBL] [Abstract][Full Text] [Related]
14. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C
Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462
[TBL] [Abstract][Full Text] [Related]
15. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
[TBL] [Abstract][Full Text] [Related]
16. Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference.
Collins D; Zhang Y; Blendy J; Kreek MJ
Neuropharmacology; 2020 May; 167():107864. PubMed ID: 31778689
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism.
Margas W; Zubkoff I; Schuler HG; Janicki PK; Ruiz-Velasco V
J Neurophysiol; 2007 Feb; 97(2):1058-67. PubMed ID: 17151221
[TBL] [Abstract][Full Text] [Related]
18. Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.
Zhang Z; Pan ZZ
J Neurosci; 2010 Mar; 30(13):4735-45. PubMed ID: 20357124
[TBL] [Abstract][Full Text] [Related]
19. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord.
Kohno T; Ji RR; Ito N; Allchorne AJ; Befort K; Karchewski LA; Woolf CJ
Pain; 2005 Sep; 117(1-2):77-87. PubMed ID: 16098668
[TBL] [Abstract][Full Text] [Related]
20. A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.
Huang P; Chen C; Mague SD; Blendy JA; Liu-Chen LY
Biochem J; 2012 Jan; 441(1):379-86. PubMed ID: 21864297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
